<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34287048</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>19</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 2A Protease Inhibits P-Body Formation To Promote Viral RNA Synthesis.</ArticleTitle><Pagination><StartPage>e0092221</StartPage><MedlinePgn>e0092221</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00922-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00922-21</ELocationID><Abstract><AbstractText>Several viruses have been proven to inhibit the formation of RNA processing bodies (P-bodies); however, knowledge regarding whether enterovirus blocks P-body formation remains unclear, and the detailed molecular mechanisms and functions of picornavirus regulation of P-bodies are limited. Here, we show the crucial role of 2A protease in inhibiting P-bodies to promote viral replication during enterovirus 71 infection. Moreover, we found that the activity of 2A protease is essential to inhibit P-body formation, which was proven by the result that infection with EV71-2A<sup>C110S</sup>, a 2A protease activity-inactivated recombinant virus, failed to block the formation of P-bodies. Furthermore, we show that DDX6, a scaffolding protein of P-bodies, interacted with viral RNA to facilitate viral replication rather than viral translation, by using a <i>Renilla</i> luciferase mRNA reporter system and nascent RNA capture assay. Altogether, our data first demonstrate that the 2A protease of enterovirus inhibits P-body formation to facilitate viral RNA synthesis by recruiting the P-body components to viral RNA. <b>IMPORTANCE</b> Processing bodies (P-bodies) are constitutively present in eukaryotic cells and play an important role in the mRNA cycle, including regulation of gene expression and mRNA degradation. The P-body is the structure that viruses manipulate to facilitate their survival. Here, we show that the 2A protease alone was efficient to block P-body formation during enterovirus 71 infection, and its activity is essential. When the assembly of P-bodies was blocked by 2A protease, DDX6 and 4E-T, which were required for P-body formation, bound to viral RNA to facilitate viral RNA synthesis. We propose a model revealing that EV71 manipulates P-body formation to generate an environment that is conducive to viral replication by facilitating viral RNA synthesis: 2A protease blocked P-body assembly to make it possible for virus to take advantage of P-body components.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zihang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mingzhou</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5308-6897</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2017YFA0505801</GrantID><Agency>National Key R&amp;amp;D Program of China</Agency><Country/></Grant><Grant><GrantID>2019ACCP-MS06</GrantID><Agency>Advanced Customer Cultivation Project of Wuhan National Biosafety Laboratory</Agency><Country/></Grant><Grant><GrantID>81825015</GrantID><Agency>National Natural Science Foundation of China (NSFC)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C411571">EIF4ENIF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029543">Nucleocytoplasmic Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012261">Ribonucleoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C094683">DDX6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D053487">DEAD-box RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003594" MajorTopicYN="N">Cytoplasmic Granules</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053487" MajorTopicYN="N">DEAD-box RNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029543" MajorTopicYN="N">Nucleocytoplasmic Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012261" MajorTopicYN="N">Ribonucleoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2A protease</Keyword><Keyword MajorTopicYN="N">DDX6/4E-T complex</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">processing body</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>21</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34287048</ArticleId><ArticleId IdType="pmc">PMC8428400</ArticleId><ArticleId IdType="doi">10.1128/JVI.00922-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. 2005. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7:719&#x2013;723. 10.1038/ncb1274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1274</ArticleId><ArticleId IdType="pmc">PMC1855297</ArticleId><ArticleId IdType="pubmed">15937477</ArticleId></ArticleIdList></Reference><Reference><Citation>Brengues M, Teixeira D, Parker R. 2005. Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 310:486&#x2013;489. 10.1126/science.1115791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1115791</ArticleId><ArticleId IdType="pmc">PMC1863069</ArticleId><ArticleId IdType="pubmed">16141371</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira D, Sheth U, Valencia-Sanchez MA, Brengues M, Parker R. 2005. Processing bodies require RNA for assembly and contain nontranslating mRNAs. RNA 11:371&#x2013;382. 10.1261/rna.7258505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.7258505</ArticleId><ArticleId IdType="pmc">PMC1370727</ArticleId><ArticleId IdType="pubmed">15703442</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth U, Parker R. 2003. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300:805&#x2013;808. 10.1126/science.1082320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1082320</ArticleId><ArticleId IdType="pmc">PMC1876714</ArticleId><ArticleId IdType="pubmed">12730603</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu JH, Yang W-H, Gulick T, Bloch KD, Bloch DB. 2005. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 11:1795&#x2013;1802. 10.1261/rna.2142405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2142405</ArticleId><ArticleId IdType="pmc">PMC1370868</ArticleId><ArticleId IdType="pubmed">16314453</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrei MA, Ingelfinger D, Heintzmann R, Achsel T, Rivera-Pomar R, Luhrmann R. 2005. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA 11:717&#x2013;727. 10.1261/rna.2340405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2340405</ArticleId><ArticleId IdType="pmc">PMC1370757</ArticleId><ArticleId IdType="pubmed">15840819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubstenberger A, Courel M, Benard M, Souquere S, Ernoult-Lange M, Chouaib R, Yi Z, Morlot JB, Munier A, Fradet M, Daunesse M, Bertrand E, Pierron G, Mozziconacci J, Kress M, Weil D. 2017. P-body purification reveals the condensation of repressed mRNA regulons. Mol Cell 68:144&#x2013;157.e5. 10.1016/j.molcel.2017.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.09.003</ArticleId><ArticleId IdType="pubmed">28965817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittag T, Parker R. 2018. Multiple modes of protein-protein interactions promote RNP granule assembly. J Mol Biol 430:4636&#x2013;4649. 10.1016/j.jmb.2018.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.08.005</ArticleId><ArticleId IdType="pmc">PMC6204294</ArticleId><ArticleId IdType="pubmed">30099026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamenska A, Simpson C, Vindry C, Broomhead H, Benard M, Ernoult-Lange M, Lee BP, Harries LW, Weil D, Standart N. 2016. The DDX6-4E-T interaction mediates translational repression and P-body assembly. Nucleic Acids Res 44:6318&#x2013;6334. 10.1093/nar/gkw565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw565</ArticleId><ArticleId IdType="pmc">PMC5291280</ArticleId><ArticleId IdType="pubmed">27342281</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Treeck B, Parker R. 2018. Emerging roles for intermolecular RNA-RNA interactions in RNP assemblies. Cell 174:791&#x2013;802. 10.1016/j.cell.2018.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.023</ArticleId><ArticleId IdType="pmc">PMC6200146</ArticleId><ArticleId IdType="pubmed">30096311</ArticleId></ArticleIdList></Reference><Reference><Citation>Eulalio A, Behm-Ansmant I, Izaurralde E. 2007. P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 8:9&#x2013;22. 10.1038/nrm2080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2080</ArticleId><ArticleId IdType="pubmed">17183357</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker CJ, Parker R. 2012. P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb Perspect Biol 4:a012286. 10.1101/cshperspect.a012286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a012286</ArticleId><ArticleId IdType="pmc">PMC3428773</ArticleId><ArticleId IdType="pubmed">22763747</ArticleId></ArticleIdList></Reference><Reference><Citation>Franks TM, Lykke-Andersen J. 2008. The control of mRNA decapping and P-body formation. Mol Cell 32:605&#x2013;615. 10.1016/j.molcel.2008.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.11.001</ArticleId><ArticleId IdType="pmc">PMC2630519</ArticleId><ArticleId IdType="pubmed">19061636</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Na Z, Slavoff SA. 2018. P-bodies: composition, properties, and functions. Biochemistry 57:2424&#x2013;2431. 10.1021/acs.biochem.7b01162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.7b01162</ArticleId><ArticleId IdType="pmc">PMC6296482</ArticleId><ArticleId IdType="pubmed">29381060</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker R, Sheth U. 2007. P bodies and the control of mRNA translation and degradation. Mol Cell 25:635&#x2013;646. 10.1016/j.molcel.2007.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.02.011</ArticleId><ArticleId IdType="pubmed">17349952</ArticleId></ArticleIdList></Reference><Reference><Citation>Reference deleted.</Citation></Reference><Reference><Citation>Ivanov P, Kedersha N, Anderson P. 2019. Stress granules and processing bodies in translational control. Cold Spring Harb Perspect Biol 11:a032813. 10.1101/cshperspect.a032813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a032813</ArticleId><ArticleId IdType="pmc">PMC6496347</ArticleId><ArticleId IdType="pubmed">30082464</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson P, Kedersha N. 2006. RNA granules. J Cell Biol 172:803&#x2013;808. 10.1083/jcb.200512082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200512082</ArticleId><ArticleId IdType="pmc">PMC2063724</ArticleId><ArticleId IdType="pubmed">16520386</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoecklin G, Kedersha N. 2013. Relationship of GW/P-bodies with stress granules. Adv Exp Med Biol 768:197&#x2013;211. 10.1007/978-1-4614-5107-5_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-5107-5_12</ArticleId><ArticleId IdType="pmc">PMC4317337</ArticleId><ArticleId IdType="pubmed">23224972</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91&#x2013;107. 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778&#x2013;790. 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating J, van Kuppeveld FJM. 2018. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368&#x2013;381. 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Liu Y, Ma HC, Paul AV, Wimmer E. 2014. Picornavirus morphogenesis. Microbiol Mol Biol Rev 78:418&#x2013;437. 10.1128/MMBR.00012-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00012-14</ArticleId><ArticleId IdType="pmc">PMC4187686</ArticleId><ArticleId IdType="pubmed">25184560</ArticleId></ArticleIdList></Reference><Reference><Citation>Dougherty JD, White JP, Lloyd RE. 2011. Poliovirus-mediated disruption of cytoplasmic processing bodies. J Virol 85:64&#x2013;75. 10.1128/JVI.01657-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01657-10</ArticleId><ArticleId IdType="pmc">PMC3014174</ArticleId><ArticleId IdType="pubmed">20962086</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahar HS, Chen S, Manjunath N. 2013. P-body components LSM1, GW182, DDX3, DDX6 and XRN1 are recruited to WNV replication sites and positively regulate viral replication. Virology 436:1&#x2013;7. 10.1016/j.virol.2012.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.09.041</ArticleId><ArticleId IdType="pmc">PMC3545066</ArticleId><ArticleId IdType="pubmed">23102969</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariumi Y, Kuroki M, Kushima Y, Osugi K, Hijikata M, Maki M, Ikeda M, Kato N. 2011. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J Virol 85:6882&#x2013;6892. 10.1128/JVI.02418-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02418-10</ArticleId><ArticleId IdType="pmc">PMC3126564</ArticleId><ArticleId IdType="pubmed">21543503</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma NR, Majerciak V, Kruhlak MJ, Yu L, Kang JG, Yang A, Gu S, Fritzler MJ, Zheng ZM. 2019. KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182. Nucleic Acids Res 47:9368&#x2013;9385. 10.1093/nar/gkz683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz683</ArticleId><ArticleId IdType="pmc">PMC6755100</ArticleId><ArticleId IdType="pubmed">31400113</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltera RF, Tershak DR. 1989. Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. J Virol 63:4441&#x2013;4444. 10.1128/jvi.63.10.4441-4444.1989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.63.10.4441-4444.1989</ArticleId><ArticleId IdType="pmc">PMC251066</ArticleId><ArticleId IdType="pubmed">2550675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenneth E, Murray MLN. 2007. Guanidine hydrochloride inhibits mammalian orthoreovirus growth by reversibly blocking the synthesis of double-stranded RNA. J Virol 81:4572&#x2013;4584. 10.1128/JVI.02106-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02106-06</ArticleId><ArticleId IdType="pmc">PMC1900160</ArticleId><ArticleId IdType="pubmed">17301147</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Hu Z, Fan S, Zhang Q, Zhong Y, Guo D, Qin Y, Chen M. 2018. Picornavirus 2A protease regulates stress granule formation to facilitate viral translation. PLoS Pathog 14:e1006901. 10.1371/journal.ppat.1006901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006901</ArticleId><ArticleId IdType="pmc">PMC5819834</ArticleId><ArticleId IdType="pubmed">29415027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR. 2009. Viral and host proteins involved in picornavirus life cycle. J Biomed Sci 16:103. 10.1186/1423-0127-16-103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-16-103</ArticleId><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Li G, Yuan S, Gao Q, Lan K, Altmeyer R, Zou G. 2016. In vitro assessment of combinations of enterovirus inhibitors against enterovirus 71. Antimicrob Agents Chemother 60:5357&#x2013;5367. 10.1128/AAC.01073-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01073-16</ArticleId><ArticleId IdType="pmc">PMC4997834</ArticleId><ArticleId IdType="pubmed">27353263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao X, Guo X, Yin M, Tariq M, Lai Y, Kanwal S, Zhou J, Li N, Lv Y, Pulido-Quetglas C, Wang X, Ji L, Khan MJ, Zhu X, Luo Z, Shao C, Lim DH, Liu X, Li N, Wang W, He M, Liu YL, Ward C, Wang T, Zhang G, Wang D, Yang J, Chen Y, Zhang C, Jauch R, Yang YG, Wang Y, Qin B, Anko ML, Hutchins AP, Sun H, Wang H, Fu XD, Zhang B, Esteban MA. 2018. Capturing the interactome of newly transcribed RNA. Nat Methods 15:213&#x2013;220. 10.1038/nmeth.4595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4595</ArticleId><ArticleId IdType="pmc">PMC5967874</ArticleId><ArticleId IdType="pubmed">29431736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozgur S, Basquin J, Kamenska A, Filipowicz W, Standart N, Conti E. 2015. Structure of a human 4E-T/DDX6/CNOT1 complex reveals the different interplay of DDX6-binding proteins with the CCR4-NOT complex. Cell Rep 13:703&#x2013;711. 10.1016/j.celrep.2015.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.09.033</ArticleId><ArticleId IdType="pubmed">26489469</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordin O, Banroques J, Tanner NK, Linder P. 2006. The DEAD-box protein family of RNA helicases. Gene 367:17&#x2013;37. 10.1016/j.gene.2005.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2005.10.019</ArticleId><ArticleId IdType="pubmed">16337753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward AM, Bidet K, Yinglin A, Ler SG, Hogue K, Blackstock W, Gunaratne J, Garcia-Blanco MA. 2011. Quantitative mass spectrometry of DENV-2 RNA-interacting proteins reveals that the DEAD-box RNA helicase DDX6 binds the DB1 and DB2 3' UTR structures. RNA Biol 8:1173&#x2013;1186. 10.4161/rna.8.6.17836.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.8.6.17836</ArticleId><ArticleId IdType="pmc">PMC3256426</ArticleId><ArticleId IdType="pubmed">21957497</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangra RK, Yi M, Lemon SM. 2010. DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation. J Virol 84:6810&#x2013;6824. 10.1128/JVI.00397-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00397-10</ArticleId><ArticleId IdType="pmc">PMC2903299</ArticleId><ArticleId IdType="pubmed">20392846</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariumi Y, Kuroki M, Kushima Y, Osugi K, Hijikata M, Maki M, Ikeda M, Kato N. 2011. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J Virol 85:6882&#x2013;6892. 10.1128/JVI.02418-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02418-10</ArticleId><ArticleId IdType="pmc">PMC3126564</ArticleId><ArticleId IdType="pubmed">21543503</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller N, Mina LB, Gal&#xe3;o RP, Chari A, Gim&#xe9;nez-Barcons M, Noueiry A, Fischer U, Meyerhans A, D&#xed;ez J. 2009. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc Natl Acad Sci USA 106:13517&#x2013;113522. 10.1073/pnas.0906413106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906413106</ArticleId><ArticleId IdType="pmc">PMC2714764</ArticleId><ArticleId IdType="pubmed">19628699</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang L, Rivera-Serrano EE, Chen X, Lemon SM. 2019. TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA. Nucleic Acids Res 47:6411&#x2013;6424. 10.1093/nar/gkz278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz278</ArticleId><ArticleId IdType="pmc">PMC6614814</ArticleId><ArticleId IdType="pubmed">30997501</ArticleId></ArticleIdList></Reference><Reference><Citation>Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT. 2004. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119:381&#x2013;392. 10.1016/j.cell.2004.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.09.029</ArticleId><ArticleId IdType="pubmed">15507209</ArticleId></ArticleIdList></Reference><Reference><Citation>Jungfleisch J, Chowdhury A, Alves-Rodrigues I, Tharun S, Diez J. 2015. The Lsm1-7-Pat1 complex promotes viral RNA translation and replication by differential mechanisms. RNA 21:1469&#x2013;1479. 10.1261/rna.052209.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.052209.115</ArticleId><ArticleId IdType="pmc">PMC4509936</ArticleId><ArticleId IdType="pubmed">26092942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilanchone V, Clemens K, Kaake R, Dawson AR, Matheos D, Nagashima K, Sitlani P, Patterson K, Chang I, Huang L, Sandmeyer S. 2015. Ty3 retrotransposon hijacks mating yeast RNA processing bodies to infect new genomes. PLoS Genet 11:e1005528. 10.1371/journal.pgen.1005528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005528</ArticleId><ArticleId IdType="pmc">PMC4589538</ArticleId><ArticleId IdType="pubmed">26421679</ArticleId></ArticleIdList></Reference><Reference><Citation>Castello A, Izquierdo JM, Welnowska E, Carrasco L. 2009. RNA nuclear export is blocked by poliovirus 2A protease and is concomitant with nucleoporin cleavage. J Cell Sci 122:3799&#x2013;3809. 10.1242/jcs.055988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.055988</ArticleId><ArticleId IdType="pubmed">19789179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora M, Marissen WE, Lloyd RE. 2002. Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells. J Virol 76:165&#x2013;177. 10.1128/JVI.76.1.165-177.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.1.165-177.2002</ArticleId><ArticleId IdType="pmc">PMC135685</ArticleId><ArticleId IdType="pubmed">11739682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YY, Liu YN, Lu WW, Kung SH. 2009. Visualizing and quantifying the differential cleavages of the eukaryotic translation initiation factors eIF4GI and eIF4GII in the enterovirus-infected cell. Biotechnol Bioeng 104:1142&#x2013;1152. 10.1002/bit.22495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bit.22495</ArticleId><ArticleId IdType="pubmed">19655339</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>